Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover

@inproceedings{Collette2009VertebralAE,
  title={Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover},
  author={Julien H Collette and Olivier Bruy{\`e}re and J. M. Kaufman and Roman S. Lorenc and Dieter Felsenberg and T. D. Spector and M. Diaz- Curiel and Steven Boonen and J. Y. L. Reginster},
  booktitle={Osteoporosis International},
  year={2009}
}
Osteoporotic post-menopausal women patients in two randomised trials comparing the anti-fracture efficacy of strontium ranelate with placebo were separated into tertiles according to their baseline levels of biochemical markers of bone formation and resorption. The vertebral anti-fracture efficacy of strontium ranelate was shown to be independent of baseline bone turnover levels. Bone turnover (BTO) levels vary among women at risk of osteoporotic fracture. Strontium ranelate is an anti… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 44 references

A crosssectional study of bone turnover markers in healthy premenopausal women

  • AE de Papp, HG Bone, MP Caulfield
  • Bone
  • 2007

resorption while maintaining bone formation in alveolar bone in monkeys ( Macaca fascicularis )

  • E Bonnelye, A Chabadel, F Saltel
  • 2007

Similar Papers

Loading similar papers…